FdaApplication
NDA 212161
Identifiers
- fda_app_no: NDA212161
Properties
| Property | Value |
|---|---|
| applicant_name | FOLDRX PHARMACEUTICALS LLC A WHOLLY OWNED SUB OF PFIZER INC |
| application_type | NDA |
| approval_date | 2019-05-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VYNDAMAX | TAFAMIDIS | 61MG | CAPSULE;ORAL |
1 product